Australia's most trusted
source of pharma news
Thursday, 21 November 2024
Posted 21 November 2024 PM
Resonance Health shares skyrocketed after the company announced it had been contracted by Indian headquartered Sun Pharma.
The clinical trials service provider went into a trading halt before announcing the news to the market, which saw it shares surge by more than 50 per cent yesterday on Tuesday.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.